FPT Software Partners with Blue Yonder to Transform Supply Chain Management Across Southeast Asia
Global IT company FPT Software announced a partnership with Blue Yonder, the world leader in digital supply chain transformations, to deliver end-to-end supply chain management solutions tailored to the needs of businesses across various industries in Southeast Asia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240829950683/en/
The partnership signing ceremony took place in Hanoi, Vietnam with Blue Yonder Asia Pacific Alliances Director Lakshmikanth Sundararajan, Blue Yonder Southeast Asia Senior Sales Director Anand Kumar, and FPT Software SEVP Nguyen Khai Hoan. (Photo: Business Wire)
The partnership targets six key markets, including Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. Leveraging Blue Yonder’s world-class supply chain solutions and FPT Software’s extensive reach and implementation experience in these markets, the partnership is expected to deliver rapid, customized supply chain management strategies that address the unique challenges faced by diverse industries in the region.
Blue Yonder offers an artificial intelligence (AI)-powered enterprise supply chain platform and industry-specific solutions that empower supply chain leaders to meet critical business objectives. The Blue Yonder Platform enables end-to-end visibility and a connected experience to deliver seamless coordination across everything from supplier orders to inventory flow and fulfilling customer commitments. It also connects the breadth of Blue Yonder’s solutions to synchronize a customer’s entire supply chain ecosystem. In turn, Blue Yonder empowers customers to improve team productivity, accelerate decision-making and build truly resilient supply chains.
Meanwhile, FPT Software, with its expansive presence and profound understanding of the business environment, customer demands, and regional cultural nuances, will play a pivotal role in facilitating Blue Yonder’s efforts to support companies in Southeast Asia with their supply chain needs.
“The demand for digital transformation in supply chain management across Asia is growing rapidly, driven by the need for enhanced efficiency, resilience, and adaptability. By combining our solid presence and network of partners and customers in this high-growth region with Blue Yonder’s expertise, we are well positioned to deliver more tailored, high-impact solutions that meet the evolving needs of businesses,” said Nguyen Khai Hoan, Senior Executive Vice President, FPT Software.
“We are pleased to partner with FPT Software, which is one of the largest IT services companies catering to a variety of enterprise customers across the globe,” said Amith Varma, Vice President, Asia, Blue Yonder. “Their leading presence in Vietnam and other Southeast Asian markets, as well as their focus on customer success, makes them a natural choice and will allow us to further our business as part of our growth initiatives in Asia Pacific.”
About FPT Software
FPT Software, a subsidiary of FPT Corporation, is a global technology and IT services provider headquartered in Vietnam, with $1 billion in revenue (2023) and over 30,000 employees in 30 countries.
The company champions complex business opportunities and challenges with its world-class services in Advanced Analytics, AI, Digital Platforms, Cloud, Hyperautomation, IoT, Low-code, and so on. It has partnered with over 1,100 clients worldwide, nearly 100 of which are Fortune Global 500 companies in Aviation, Automotive, Banking, Financial Services and Insurance, Healthcare, Logistics, Manufacturing, Utilities, and more. For more information, please visit https://fptsoftware.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20240829950683/en/
Contacts
Media
Mai Duong (Ms.)
FPT Software
PR Manager
MCP.PR@fpt.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wipro Appoints Srikumar Rao as Global Head of Its Engineering Edge Business Line30.8.2024 16:20:00 CEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading technology services and consulting company, today announced the appointment of Srikumar Rao as Global Head of its Engineering Edge Business Line, effective from October 5, 2024. Srikumar succeeds Harmeet Chauhan, who is stepping down to pursue opportunities outside the organization. Srikumar will report to Srini Pallia. Srikumar has been with Wipro for 26 years and has grown with the organization, serving in various leadership roles. He was most recently the Chief Operating Officer (COO) of Wipro Engineering Edge (WEE) and Global Practice Head of Embedded Systems. His work has spanned several markets, selling and delivering specialized Engineering, Research, and Development (ER&D) services to Software & Internet, Semiconductor, Automotive, Manufacturing, and Communications clients. In his new role, Srikumar will continue to scale and strengthen Wipro’s engineering prowess. He will also be responsible for defining the vision
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress30.8.2024 12:00:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced detailed results from the HELIOS-B Phase 3 study of vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). The data were presented today in a Hot Line session at the European Society of Cardiology (ESC) Congress 2024, taking place August 30-September 2 in London, United Kingdom. Results from the HELIOS-B study were also simultaneously published in TheNew England Journal of Medicine. As previously reported, the HELIOS-B study met all 10 of its primary and secondary endpoints, across both the overall and monotherapy populations, with statistical significance. Enrolled patients were predominantly New York Heart Association (NYHA) Class I or II with wild-type disease and had been diagnosed by non-invasive methods, with substantial concurrent treatment with available standard of care treatments such as tafamidis and
PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support Development of Cell and Gene Therapy Products Manufacturing Process30.8.2024 09:12:00 CEST | Press release
PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as "Biomedical Division") will showcase a prototype of its new cell expansion system LiCellGrow at the ISCT (International Society for Cell & Gene Therapy) Europe 2024 Regional Meeting held in Gothenburg, Sweden on September 4-6. LiCellGrow, currently under development, is designed to allow pharmaceutical companies to visualize continuous metabolic changes in cells in real-time and adjust the cell culture automatically to optimize conditions for cell growth. The system seeks to expand availability of cell and gene therapy (CGT) products by accelerating the manufacturing of specific cells needed for these therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240830467786/en/ (Graphic: Business Wire) CGT, in which a patient’s cells are removed, modified, and reintroduced to the body to fight disease, h
Kaneka Completes Construction of Medical Device Plant in Hokkaido30.8.2024 07:34:00 CEST | Press release
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) opened its Tomatoh Manufacturing Site in the Tomakomai Tobu Area of Hokkaido for the purpose of portfolio transformation and business expansion and held the opening ceremony on August 26. The Tomatoh Manufacturing Site is the seventh domestic business location*1 for the company and the first new one in 54 years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240829240050/en/ Tomatoh Manufacturing Site (Photo: Business Wire) The medical device plant*2 completed at Tomatoh Manufacturing Site will produce adsorption type blood purification devices "Rheocarna™" and adsorption type plasma purification devices "Liposorber™". The number of patients with arteriosclerosis obliterans (ASO)*3, which these medical devices are intended to treat, is on the rise worldwide, along with increases in diabetes, chronic renal failure, and other conditions
Rimini Street Honored as Best Workplaces™ for Millennials 2024 India and a Great Place to Work® Australia29.8.2024 22:30:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and an AWS partner, proudly announces that Rimini Street India has been awarded as one of the Best Workplaces™ for Millennials, and Rimini Street Australia has been honored as a Great Place to Work® 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240829270348/en/ Rimini Street Honored as Best Workplaces™ for Millennials 2024 India and a Great Place to Work® Australia (Photo: Business Wire) Great Place to Work® is the global authority on workplace culture, employee experience, and leadership behaviors proven to deliver market-leading revenue, employee retention, and increased innovation. Best Workplaces™ awards are granted upon review of the detailed Culture Brief™ benchmarked against industry and regional peers. “Rimini Street contin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom